Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Taheri-Ghahfarokhi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2015
Inducing Pluripotency in CattleLuis F Malaver-Ortega, Amir Taheri-Ghahfarokhi, Huseyin Sumer
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2015
Genome Modification of Pluripotent Cells by Using Transcription Activator-Like Effector Nucleases (TALENs)Amir Taheri-Ghahfarokhi, Luis F Malaver-Ortega, Huseyin Sumer
Methods in Molecular Biology (Clifton, N.J.)|June 13, 2022
Tools for Efficient Genome Editing; ZFN, TALEN, and CRISPRYasaman Shamshirgaran, Jun Liu, Huseyin Sumer, et al.
Oncotarget|May 17, 2018
Functional significance of co-occurring mutations in <i>PIK3CA</i> and <i>MAP3K1</i> in breast cancerAlvaro Avivar-Valderas, Robert McEwen, Amir Taheri-Ghahfarokhi, et al.
Nucleic Acids Research|July 23, 2018
Decoding non-random mutational signatures at Cas9 targeted sitesAmir Taheri-Ghahfarokhi, Benjamin J M Taylor, Roberto Nitsch, et al.
Ebiomedicine|March 4, 2018
Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency PhenotypeMikael Bjursell, Michelle J Porritt, Elke Ericson, et al.
BMC Biology|January 17, 2019
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse modelAlba Carreras, Luna Simona Pane, Roberto Nitsch, et al.
Stem Cell Research|May 8, 2018
NKX6.1 induced pluripotent stem cell reporter lines for isolation and analysis of functionally relevant neuronal and pancreas populationsShailesh Kumar Gupta, Agata Wesolowska-Andersen, Anna K Ringgaard, et al.
Nature Communications|September 30, 2020
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discoveryAnders Lundin, Michelle J Porritt, Himjyot Jaiswal, et al.
Nature Communications|September 6, 2023
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivoBurcu Bestas, Sandra Wimberger, Dmitrii Degtev, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2015
Inducing Pluripotency in CattleLuis F Malaver-Ortega, Amir Taheri-Ghahfarokhi, Huseyin Sumer
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2015
Genome Modification of Pluripotent Cells by Using Transcription Activator-Like Effector Nucleases (TALENs)Amir Taheri-Ghahfarokhi, Luis F Malaver-Ortega, Huseyin Sumer
Methods in Molecular Biology (Clifton, N.J.)|June 13, 2022
Tools for Efficient Genome Editing; ZFN, TALEN, and CRISPRYasaman Shamshirgaran, Jun Liu, Huseyin Sumer, et al.
Oncotarget|May 17, 2018
Functional significance of co-occurring mutations in <i>PIK3CA</i> and <i>MAP3K1</i> in breast cancerAlvaro Avivar-Valderas, Robert McEwen, Amir Taheri-Ghahfarokhi, et al.
Nucleic Acids Research|July 23, 2018
Decoding non-random mutational signatures at Cas9 targeted sitesAmir Taheri-Ghahfarokhi, Benjamin J M Taylor, Roberto Nitsch, et al.
Ebiomedicine|March 4, 2018
Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency PhenotypeMikael Bjursell, Michelle J Porritt, Elke Ericson, et al.
BMC Biology|January 17, 2019
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse modelAlba Carreras, Luna Simona Pane, Roberto Nitsch, et al.
Stem Cell Research|May 8, 2018
NKX6.1 induced pluripotent stem cell reporter lines for isolation and analysis of functionally relevant neuronal and pancreas populationsShailesh Kumar Gupta, Agata Wesolowska-Andersen, Anna K Ringgaard, et al.
Nature Communications|September 30, 2020
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discoveryAnders Lundin, Michelle J Porritt, Himjyot Jaiswal, et al.
Nature Communications|September 6, 2023
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivoBurcu Bestas, Sandra Wimberger, Dmitrii Degtev, et al.
Pageof 2